MJBizDaily’s most popular cannabis business stories of 2023
MJBizDaily lists its most clicked-on cannabis stories of 2023, including those about a dangerous viroid, delta-8 THC and rescheduling.
MJBizDaily lists its most clicked-on cannabis stories of 2023, including those about a dangerous viroid, delta-8 THC and rescheduling.
New York regulators are facing yet another lawsuit aimed at stopping them from issuing any additional adult-use marijuana licenses.
After a long career in journalism and almost eight years with MJBizDaily, Roger Fillion will retire as editorial director and will be succeeded by the publishing platform’s magazine editor Kate Lavin, MJBiz announced Wednesday.
An administrative judge in Florida gave the thumbs-up to a new rule adopted a year ago by state regulators that boosted the biennial license renewal fee for medical marijuana companies in the state by more than twentyfold, to $1.3 million.
Cannabis multistate operator Jushi Holdings filed a preliminary short-form base shelf prospectus in Canada to raise up to 600 million Canadian dollars ($442 million) by issuing a variety of securities over a 25-month period.
Pamela Moore, the chief content strategy officer for MJBiz, is leaving the pioneering cannabis publishing and trade show company after four years.
Tilt Holdings, a Phoenix-based diversified marijuana company, has cut ties with three social equity brands and paused a joint venture with the Shinnecock Indian Nation in New York.
Cannabis cultivators are caught up in a dilemma about providing clean and safe product that has passed inspection for acceptable levels of microbial contaminants.
Marijuana companies can offer a more personalized cannabis experience for consumers by digging deeper into data about customer preferences.
Combining cannabinoids with psilocybin into a single formula for treating both physical and mental health issues took another step closer to reality as described in a product patent from a major cannabinoid laboratory, CaaMTech.
Twitter might have further eased its rules for cannabis advertising, but the changes don’t seem to have made it any easier for marijuana businesses to take advantage of the social media platform’s wide reach.
Connecticut legislators took the first step toward outlawing synthetic marijuana and imposing THC caps on sleep aids and other consumable products sold in convenience and CBD stores outside the state’s regulated medical and recreational cannabis markets.